1. Home
  2. YMAB vs NNE Comparison

YMAB vs NNE Comparison

Compare YMAB & NNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • NNE
  • Stock Information
  • Founded
  • YMAB 2015
  • NNE 2022
  • Country
  • YMAB United States
  • NNE United States
  • Employees
  • YMAB N/A
  • NNE N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • NNE
  • Sector
  • YMAB Health Care
  • NNE
  • Exchange
  • YMAB Nasdaq
  • NNE NYSE
  • Market Cap
  • YMAB 631.1M
  • NNE 718.5M
  • IPO Year
  • YMAB 2018
  • NNE 2024
  • Fundamental
  • Price
  • YMAB $11.14
  • NNE $21.70
  • Analyst Decision
  • YMAB Strong Buy
  • NNE Strong Buy
  • Analyst Count
  • YMAB 8
  • NNE 2
  • Target Price
  • YMAB $21.38
  • NNE $58.00
  • AVG Volume (30 Days)
  • YMAB 268.9K
  • NNE 5.7M
  • Earning Date
  • YMAB 11-08-2024
  • NNE 11-26-2024
  • Dividend Yield
  • YMAB N/A
  • NNE N/A
  • EPS Growth
  • YMAB N/A
  • NNE N/A
  • EPS
  • YMAB N/A
  • NNE N/A
  • Revenue
  • YMAB $84,553,000.00
  • NNE N/A
  • Revenue This Year
  • YMAB $10.24
  • NNE N/A
  • Revenue Next Year
  • YMAB $20.21
  • NNE N/A
  • P/E Ratio
  • YMAB N/A
  • NNE N/A
  • Revenue Growth
  • YMAB N/A
  • NNE N/A
  • 52 Week Low
  • YMAB $5.17
  • NNE $3.25
  • 52 Week High
  • YMAB $20.90
  • NNE $37.51
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 25.01
  • NNE N/A
  • Support Level
  • YMAB $12.47
  • NNE N/A
  • Resistance Level
  • YMAB $15.69
  • NNE N/A
  • Average True Range (ATR)
  • YMAB 0.97
  • NNE 0.00
  • MACD
  • YMAB -0.46
  • NNE 0.00
  • Stochastic Oscillator
  • YMAB 9.88
  • NNE 0.00

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About NNE NANO NUCLEAR ENERGY INC

Nano Nuclear Energy Inc is an early-stage nuclear energy company developing smaller, cheaper, and safer advanced portable clean energy solutions. It is focused on four business lines as part of development: Micro Nuclear Reactor Business is developing the next-generation nuclear microreactors, in particular ZEUS, a solid core battery reactor, and ODIN, a low-pressure salt coolant reactor. Fuel Fabrication Business, Fuel Transportation Business and Nuclear Consultation Services.

Share on Social Networks: